Cargando…

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy

Detalles Bibliográficos
Autores principales:	Yalcin, Arzu Didem, Genc, Gizem, Gumuslu, Saadet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643244/ http://dx.doi.org/10.1186/1939-4551-6-S1-P153

Ejemplares similares

Mechanisims of asthma and allergic disease - 1088. Increased serum strail level in newly diagnosed stave-iv lung adenocarcinoma but not sqamous cell carcinoma, is correlated with age and smoking
por: Kargi, Aysegul, et al.
Publicado: (2013)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers
por: Arık, Hasan Onur, et al.
Publicado: (2013)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
por: Yalcin, Ata Nevzat, et al.
Publicado: (2015)

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Evaluation of sOX-2 levels in type2 diabetic foot and nephropathic patients: association with disease activity
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

367 Evaluation of Allergen Sensitivity in Patients with Contact Dermatitis in Antalya
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Vitamin D serum levels in allergic rhinitis
por: Kose, Sukran, et al.
Publicado: (2015)

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in mediterranean region between 2011 and 2012
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: Association with disease activity
por: Arik, Hasan Onur, et al.
Publicado: (2014)

Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

384 Jessner-kanoff Lymphocytic Infiltrate as a Side Effect of Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Impact of subcutaneous specific-allergen immunotherapy in the quality of life of brazilian moderate/severe atopic dermatitis patients
por: Teixeira, Ana Julia, et al.
Publicado: (2015)

Immunotherapy – 2077. Allergen specific immunotherapy in allergic conjuntivitis due to dust mite
por: Pawar, Sanjay
Publicado: (2013)

There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders
por: Akman-Karakaş, Ayşe, et al.
Publicado: (2013)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

233 The Evaluation of Allergen Sensitivity in Allergic Rhinoconjunctivitis and Allergic Asthma Patients in Antalya, Turkey
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

426 The Evaluation of Allergen Sensitivity in Food Allergy Patients in Antalya, Turkey
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
por: Bisgin, Atil, et al.
Publicado: (2012)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

An Overview of the Effects of anti-IgE Therapies
por: Yalcin, Arzu Didem
Publicado: (2014)

Advances in Anti-IgE Therapy
por: Yalcin, Arzu Didem
Publicado: (2015)

2078- Immunotherapy – 2078. Allergen-specific oral immunotherapy for peanut allergy: a Cochrane systematic review
por: Nurmatov, Ulugbek, et al.
Publicado: (2013)

Immunotherapy – 2073. Therapeutic effect of mite allergen vaccines by subcutaneous route in allergic Cuban asthmatic patients
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Epidemiological survey on the practice of allergen immunotherapy in Brazil
por: De Magalhães Rios, José Luiz, et al.
Publicado: (2015)

277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Allergological work-up in the suspicion of drug hypersensitivity in patients undergoing allergen-specific immunotherapy
por: Furlan, Catarina, et al.
Publicado: (2015)

Physicians' attitude to allergen immunotherapy (AIT) prescription: an Italian survey
por: Modiano, Ambra
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d7amu9407pq30p91skplkndmgp